This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Taisho Pharmaceutical Holdings Bilan de santé
Santé financière contrôle des critères 6/6
Taisho Pharmaceutical Holdings has a total shareholder equity of ¥857.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1,005.5B and ¥148.2B respectively. Taisho Pharmaceutical Holdings's EBIT is ¥18.9B making its interest coverage ratio -4. It has cash and short-term investments of ¥266.4B.
Informations clés
0%
Ratio d'endettement
JP¥0
Dette
| Ratio de couverture des intérêts | -4x |
| Argent liquide | JP¥266.37b |
| Fonds propres | JP¥857.30b |
| Total du passif | JP¥148.17b |
| Total des actifs | JP¥1.01t |
Mises à jour récentes de la santé financière
Recent updates
Analyse de la situation financière
Passif à court terme: TAIS.F's short term assets (¥416.8B) exceed its short term liabilities (¥80.8B).
Passif à long terme: TAIS.F's short term assets (¥416.8B) exceed its long term liabilities (¥67.3B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: TAIS.F is debt free.
Réduire la dette: TAIS.F has not had any debt for past 5 years.
Couverture de la dette: TAIS.F has no debt, therefore it does not need to be covered by operating cash flow.
Couverture des intérêts: TAIS.F has no debt, therefore coverage of interest payments is not a concern.